VERTEX CELL AND GENETIC THERAPIES
Live / Registered — Registered (as of 05 Aug 2025)
What this means for you
Registered since 05 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98195949
- Registration number
- 7883674
- Mark type
- Stylized text
- Filed
- 25 Sept 2023
- Published for opposition
- 30 Jul 2024
- Registered
- 05 Aug 2025
- Attorney of record
- Lisa Tittemore
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research; medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 05 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Mar 2025 — USE AMENDMENT FILED
- 22 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 24 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jul 2024 — PUBLISHED FOR OPPOSITION
- 10 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE